DK0780397T3 - 17alfa-cyanomethylestra-4,9-dien-derivater, fremgangsmåde til deres fremstilling og farmaceutiske præparater indeholdende d - Google Patents

17alfa-cyanomethylestra-4,9-dien-derivater, fremgangsmåde til deres fremstilling og farmaceutiske præparater indeholdende d

Info

Publication number
DK0780397T3
DK0780397T3 DK96120293T DK96120293T DK0780397T3 DK 0780397 T3 DK0780397 T3 DK 0780397T3 DK 96120293 T DK96120293 T DK 96120293T DK 96120293 T DK96120293 T DK 96120293T DK 0780397 T3 DK0780397 T3 DK 0780397T3
Authority
DK
Denmark
Prior art keywords
17alpha
preparation
pharmaceutical compositions
compositions containing
cyanomethyl ester
Prior art date
Application number
DK96120293T
Other languages
English (en)
Inventor
Doris Dr Huebler
Gerhard Teichmueller
Gerd Mueller
Sigfrid Prof-Dr Schwarz
Bernd Dr Undeutsch
Harry Henkel
Ronald Gebuehr
Guenter Dr Kaufmann
Michael Prof-Dr Oettel
Original Assignee
Jenapharm Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE1995148449 external-priority patent/DE19548449A1/de
Priority claimed from DE1995148450 external-priority patent/DE19548450A1/de
Application filed by Jenapharm Gmbh filed Critical Jenapharm Gmbh
Application granted granted Critical
Publication of DK0780397T3 publication Critical patent/DK0780397T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton
    • C07J41/0016—Oximes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/34—Gestagens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0094—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 containing nitrile radicals, including thiocyanide radicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK96120293T 1995-12-22 1996-12-18 17alfa-cyanomethylestra-4,9-dien-derivater, fremgangsmåde til deres fremstilling og farmaceutiske præparater indeholdende d DK0780397T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE1995148449 DE19548449A1 (de) 1995-12-22 1995-12-22 17alpha-Cyanomethyl-3-oxyiminoestra-4,9-dien-3-on-17beta-yl-derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen
DE1995148450 DE19548450A1 (de) 1995-12-22 1995-12-22 17alpha-Cyanomethylestra-4,9-dien-3-on-17beta-yl- derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen

Publications (1)

Publication Number Publication Date
DK0780397T3 true DK0780397T3 (da) 1999-03-29

Family

ID=26021644

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96120293T DK0780397T3 (da) 1995-12-22 1996-12-18 17alfa-cyanomethylestra-4,9-dien-derivater, fremgangsmåde til deres fremstilling og farmaceutiske præparater indeholdende d

Country Status (10)

Country Link
US (1) US5866559A (da)
EP (1) EP0780397B1 (da)
JP (1) JP2834721B2 (da)
AT (1) ATE167190T1 (da)
CA (1) CA2193610A1 (da)
CL (1) CL2004000676A1 (da)
DE (1) DE59600274D1 (da)
DK (1) DK0780397T3 (da)
ES (1) ES2120267T3 (da)
GR (1) GR3027627T3 (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040167111A1 (en) * 1998-04-15 2004-08-26 Michael Oettel Pharmaceutical preparations for treating side effects during and/or after GnRHa therapy
US20080214512A1 (en) * 2007-03-01 2008-09-04 Christian Seitz Pharmaceutical preparation containing a gestagen, and kit and method for treating endometriosis using the preparation

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3337537A (en) * 1961-03-31 1967-08-22 Merck & Co Inc 17alpha-unsaturated-halohydrocarbon-17beta-hydroxy-19-nor-4, 9-androstadiene-3-one 17-ethers
US3907844A (en) * 1971-06-17 1975-09-23 Sandoz Ag 3-Oximino-17{60 -propadienyl-substituted-4,9-gonadienes
US3904611A (en) * 1972-10-16 1975-09-09 Syntex Corp Preparation of 17' -propadienyl steroids
US3961053A (en) * 1973-05-08 1976-06-01 Sandoz, Inc. Substituted carbinol derivatives
DE2718872A1 (de) 1976-06-14 1977-12-22 Jenapharm Veb Verfahren zur herstellung von neuen gona-4,9(10)-dienen
JP3828926B2 (ja) * 1993-08-04 2006-10-04 アクゾ・ノベル・エヌ・ベー 不安症の治療用抗グルココルチコイドステロイド
CN1072678C (zh) * 1994-05-30 2001-10-10 中国科学院上海有机化学研究所 三氟甲基甾体化合物、制备及其用途

Also Published As

Publication number Publication date
ATE167190T1 (de) 1998-06-15
CL2004000676A1 (es) 2005-01-14
DE59600274D1 (de) 1998-07-16
ES2120267T3 (es) 1998-10-16
EP0780397B1 (de) 1998-06-10
CA2193610A1 (en) 1997-06-23
JPH09183793A (ja) 1997-07-15
US5866559A (en) 1999-02-02
GR3027627T3 (en) 1998-11-30
JP2834721B2 (ja) 1998-12-14
EP0780397A2 (de) 1997-06-25
EP0780397A3 (de) 1997-07-23

Similar Documents

Publication Publication Date Title
LV12618A (en) Use of sulphamate derivatives as steroid sulphatase inhibitors
KR940703842A (ko) 5-0-데소사미닐에리쓰로노라이드 유도체
TR199901578T2 (xx) Klaritromisin form 0 kristali
NO960177D0 (no) Fremgangsmåte for fremstilling av sakaridsammensetninger
NO20003514L (no) Hypolipidemiske benzothiazepin-forbindelser
NO973222L (no) Nye farnesyl-transferase-inhibitorer, deres fremstilling samt farmasöytiske preparater inneholdende inhibitorene
HUT70435A (en) Process to prepare glycosphingolipid derivatives and pharmaceutical compositions containing them
FI893359A0 (fi) Fr 901228-foerening och foerfarande foer dess framstaellning.
ATE16488T1 (de) M-4- und isom-4-derivate, ihre herstellung und diese enthaltende zusammensetzungen.
AU548974B2 (en) Oligoglucoside derivatives
AU581442B2 (en) 2-substituted-1, 3-propylidenediphosphonate derivatives, the process for their preparation and pharmaceutical compositions containing them
DK0614362T5 (da) Farmaceutiske præparater på basis af ebastin eller dermed analoge forbindelser
DK0780397T3 (da) 17alfa-cyanomethylestra-4,9-dien-derivater, fremgangsmåde til deres fremstilling og farmaceutiske præparater indeholdende d
DE69813855D1 (de) Oligosaccharidderivate und verfahren zu ihrer herstellung
FR2688004B1 (da)
ATE35812T1 (de) Gamma-butyrolactonderivate, verfahren zur herstellung derselben und dieselben als aktive bestandteile enthaltende immunomodulierende zubereitungen.
ZA935865B (en) 17-(3-furyl) and 17-(4-pyridazinyl)-5Béta 14Béta-androstane derivatives active on the cardiovascular system processes for their preparation and pharmaceutical compositions containing same
HUT55349A (en) Process for producing benzanilide derivatives and pharmaceutical compositions comprising same
EP0974598A3 (fr) Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments
GR3031118T3 (en) Novel seco-D steroids active in the cardiovascular system and pharmaceutical compositions containing same
IL87799A0 (en) Saccharide derivatives,their preparation and pharmaceutical compositions containing them
ES8506011A1 (es) Procedimiento para la obtencion de un derivado de tetrahidrobenzotiazol
DK32789D0 (da) Derivat af antibiotikum
FR2611713B1 (fr) Nouveaux derives de l'acide (dihydro-2,3 oxo-2 benzofurannyl-3)-2 acetique, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent
FR2645864B1 (fr) Nouveaux derives alcoyles en 17/21 de la 19-nor progesterone, leurs procedes d'obtention et les compositions pharmaceutiques en renfermant